Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Overview of attention for article published in Neurology: Neuroimmunology and Neuroinflammation, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

news: 1 news outlet

twitter: 30 X users

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 1 news story.

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab – MyNeuroNews

MyNeuroNews, 26 Apr 2021

Objectives The study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.